Immunotech Biopharm Ltd
HKEX:6978.HK
2.84 (HKD) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||||||||
| Current Assets: | |||||||||||||||||||
| Cash & Cash Equivalents
| 52.161 | 52.161 | 133.74 | 133.74 | 58.448 | 58.448 | 215.968 | 215.968 | 353.341 | 353.341 | 458.468 | 458.468 | 845.386 | 845.386 | 174.229 | 174.229 | 282.247 | 282.247 | -174.022 |
| Short Term Investments
| 124.812 | 124.812 | 133.136 | 110.847 | 21.01 | 21.01 | 166.506 | 0 | 0 | 0 | 100.58 | 100.58 | 0 | 0 | 0 | 0 | 0 | 0 | 348.044 |
| Cash and Short Term Investments
| 176.973 | 176.973 | 266.876 | 266.876 | 79.458 | 79.458 | 215.968 | 215.968 | 353.341 | 353.341 | 559.048 | 559.048 | 845.386 | 845.386 | 174.229 | 174.229 | 282.247 | 282.247 | 174.022 |
| Net Receivables
| -0.125 | -124.812 | -0.022 | -22.289 | -0.021 | -21.01 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 4.924 | 4.924 | 6.196 | 6.196 | 7.213 | 7.213 | 10.209 | 10.209 | 10.866 | 10.866 | 8.335 | 8.335 | 3.975 | 3.975 | 3.562 | 3.562 | 4.81 | 4.81 | 0 |
| Other Current Assets
| 0.157 | 156.809 | 0.065 | 65.44 | 0.052 | 52.453 | 36.769 | 36.769 | 47.993 | 47.993 | 53.307 | 53.307 | 34.362 | 34.362 | 30.134 | 30.134 | 21.093 | 21.093 | 0 |
| Total Current Assets
| 213.894 | 213.894 | 316.223 | 316.223 | 118.114 | 118.114 | 262.946 | 262.946 | 412.2 | 412.2 | 620.69 | 620.69 | 883.723 | 883.723 | 207.925 | 207.925 | 308.15 | 308.15 | 174.022 |
| Non-Current Assets: | |||||||||||||||||||
| Property, Plant & Equipment, Net
| 500.759 | 500.759 | 505.598 | 505.598 | 527.251 | 527.251 | 461.398 | 461.398 | 426.588 | 426.588 | 201.321 | 201.321 | 154.492 | 154.492 | 131.641 | 131.641 | 85.35 | 85.35 | 0 |
| Goodwill
| 0 | 0 | 42.812 | 0 | 0 | 0 | 35.417 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 41.882 | 41.882 | 0.043 | 42.855 | 42.486 | 42.486 | 0.035 | 35.452 | 14.25 | 14.25 | 8.224 | 8.224 | 7.371 | 7.371 | 7.821 | 7.821 | 7.767 | 7.767 | 0 |
| Goodwill and Intangible Assets
| 41.882 | 41.882 | 42.855 | 42.855 | 42.486 | 42.486 | 35.452 | 35.452 | 14.25 | 14.25 | 8.224 | 8.224 | 7.371 | 7.371 | 7.821 | 7.821 | 7.767 | 7.767 | 0 |
| Long Term Investments
| 0.046 | 46.362 | -4.366 | 128.77 | 119.165 | 140.175 | 0.167 | 166.673 | 163.176 | 163.176 | 81.389 | 181.969 | 131.969 | 131.969 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 89.659 | 0 | 0 | 0 | -119.165 | 0 | -0.167 | 0 | -163.176 | 0 | 0 | 0 | -131.969 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.043 | 43.387 | 177.48 | 44.344 | 191.586 | 51.411 | 217.751 | 51.078 | 244.651 | 81.475 | 185.676 | 85.096 | 164.643 | 32.674 | 17.083 | 17.083 | 15.704 | 15.704 | -174.022 |
| Total Non-Current Assets
| 632.39 | 632.39 | 721.567 | 721.567 | 761.323 | 761.323 | 714.601 | 714.601 | 685.489 | 685.489 | 476.61 | 476.61 | 326.506 | 326.506 | 156.545 | 156.545 | 108.821 | 108.821 | -174.022 |
| Total Assets
| 846.284 | 846.284 | 1,037.79 | 1,037.79 | 879.437 | 879.437 | 977.547 | 977.547 | 1,097.689 | 1,097.689 | 1,097.3 | 1,097.3 | 1,210.229 | 1,210.229 | 364.47 | 364.47 | 416.971 | 416.971 | 0 |
| Liabilities & Equity: | |||||||||||||||||||
| Current Liabilities: | |||||||||||||||||||
| Account Payables
| 46.76 | 46.76 | 34.338 | 34.338 | 37.394 | 37.394 | 38.315 | 38.315 | 32.152 | 32.152 | 17.64 | 17.64 | 5.84 | 5.84 | 3.697 | 3.697 | 4.632 | 4.632 | 0 |
| Short Term Debt
| 24.679 | 0 | 25.195 | 0 | 26.056 | 0 | 21.783 | 0 | 20.209 | 0 | 8.981 | 0 | 7.204 | 0 | 3.717 | 0 | 3.786 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 131.84 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15.034 | 0 | 50.02 | 0 | 19.212 | 0 | 0 |
| Other Current Liabilities
| 0.157 | 156.676 | 115.002 | 140.197 | 145.024 | 171.08 | 109.601 | 131.384 | 127.74 | 147.949 | 17.285 | 26.266 | 3.539 | 25.777 | 197.52 | 59.735 | 178.54 | 29.431 | 0 |
| Total Current Liabilities
| 203.436 | 203.436 | 174.535 | 174.535 | 208.474 | 208.474 | 169.699 | 169.699 | 180.101 | 180.101 | 43.906 | 43.906 | 31.617 | 31.617 | 254.954 | 63.432 | 206.17 | 34.063 | 0 |
| Non-Current Liabilities: | |||||||||||||||||||
| Long Term Debt
| 432.494 | 432.494 | 435.989 | 435.989 | 123.75 | 123.75 | 79.581 | 79.581 | 90.845 | 90.845 | 43.673 | 43.673 | 43.856 | 43.856 | 33.305 | 33.305 | 35.214 | 35.214 | 0 |
| Deferred Revenue Non-Current
| 39.464 | 0 | 39.499 | 0 | 40.844 | 0 | 44.703 | 0 | 3.564 | 0 | 3.853 | 0 | 5.908 | 0 | 4.83 | 0 | 5.252 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| -0.039 | 0 | 0.321 | 0 | 0.001 | 0 | 0.001 | 0 | 5.8 | 0 | -3.853 | 0 | -2.504 | 0 | -1.071 | 0 | -1.138 | 0 | 0 |
| Other Non-Current Liabilities
| 0.039 | 39.464 | -0.321 | 39.499 | -0.001 | 40.844 | -0.001 | 44.703 | -5.8 | 3.564 | 3.853 | 3.853 | 2.504 | 5.908 | 1.071 | 4.83 | 1.138 | 5.252 | 0 |
| Total Non-Current Liabilities
| 471.958 | 471.958 | 475.488 | 475.488 | 164.594 | 164.594 | 124.284 | 124.284 | 94.409 | 94.409 | 47.526 | 47.526 | 49.764 | 49.764 | 38.135 | 38.135 | 40.466 | 40.466 | 0 |
| Total Liabilities
| 675.394 | 675.394 | 650.023 | 650.023 | 373.068 | 373.068 | 293.983 | 293.983 | 274.51 | 274.51 | 91.432 | 91.432 | 81.381 | 81.381 | 293.089 | 101.567 | 246.636 | 74.529 | 0 |
| Equity: | |||||||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 583.816 | 0 | 401.21 | 0 | 610.994 | 0 | 191.522 | 191.522 | 172.107 | 172.107 | 0 |
| Common Stock
| 3.576 | 3.576 | 3.576 | 3.576 | 3.576 | 3.576 | 3.576 | 3.576 | 3.576 | 3.576 | 3.576 | 3.576 | 3.576 | 3.576 | 0.677 | 0.677 | 0.677 | 0.677 | 0 |
| Retained Earnings
| -1,620.147 | -1,618.146 | -1.401 | -1,401.441 | -1.283 | -1,283.327 | -1.106 | -1,105.546 | -965.218 | -965.218 | -758.29 | -758.29 | -610.994 | -610.994 | -260.881 | 0 | -171.947 | -171.947 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 0.17 | 385.687 | 0.386 | 385.688 | 0.386 | 385.687 | 0.384 | 383.986 | 381.402 | 381.402 | 357.08 | 357.08 | -28.42 | 332.457 | 69.359 | 69.359 | -15.9 | 180.754 | 214.651 |
| Other Total Stockholders Equity
| 1,790.017 | 1,402.499 | 387.761 | 1,402.497 | 505.757 | 1,402.499 | 681.66 | 1,402.498 | 818.683 | 1,402.499 | 1,001.289 | 1,402.499 | 1,152.381 | 1,402.498 | 69.359 | 0 | 184.005 | 159.458 | 1.646 |
| Total Shareholders Equity
| 173.616 | 173.616 | 390.321 | 390.32 | 508.435 | 508.435 | 684.514 | 684.514 | 822.259 | 822.259 | 1,004.865 | 1,004.865 | 1,127.537 | 1,127.537 | 70.036 | 261.558 | 168.942 | 341.049 | 216.297 |
| Total Equity
| 170.89 | 170.89 | 387.767 | 387.766 | 506.369 | 506.369 | 683.564 | 683.564 | 823.179 | 823.179 | 1,005.868 | 1,005.868 | 1,128.848 | 1,128.848 | 71.381 | 262.903 | 170.335 | 342.442 | 216.297 |
| Total Liabilities & Shareholders Equity
| 846.284 | 846.284 | 1,037.79 | 1,037.789 | 879.437 | 879.437 | 977.547 | 977.547 | 1,097.689 | 1,097.689 | 1,097.3 | 1,097.3 | 1,210.229 | 1,210.229 | 364.47 | 364.47 | 416.971 | 416.971 | 216.297 |